Chromoendoscopy versus standard colonoscopy for detection of nonpolypoid dysplasia in patients with inflammatory bowel disease.

Show simple item record

dc.contributor.author Sekra, Anurag
dc.contributor.author Schauer, Cameron
dc.contributor.author Mills, Lucy
dc.contributor.author Vandal, Alain C
dc.contributor.author Rose, Toby
dc.contributor.author Lal, Dinesh
dc.contributor.author Ogra, Ravinder
dc.coverage.spatial New Zealand
dc.date.accessioned 2023-07-20T02:16:04Z
dc.date.available 2023-07-20T02:16:04Z
dc.date.issued 2018-07
dc.identifier.citation (2018). New Zealand Medical Journal, 131(1478), 32-38.
dc.identifier.issn 0028-8446
dc.identifier.uri https://hdl.handle.net/2292/64922
dc.description.abstract <h4>Aim</h4>Inflammatory bowel disease (IBD) is associated with an increased risk of colorectal cancer. Studies show that chromoendoscopy (CE) can increase the detection of dysplasia at surveillance colonoscopy, compared to standard white light endoscopy (WLE). We performed a retrospective cohort study to compare standard WLE to CE with targeted biopsies in detecting nonpolypoid dysplasia in IBD patients undergoing surveillance colonoscopy at a single tertiary centre.<h4>Method</h4>Data was collected on 110 consecutive patients with IBD who underwent surveillance colonoscopy from 1 August 2015 to 31 July 2017 at Counties Manukau District Health Board, Auckland. Patients had either WLE or CE. Patient characteristics, endoscopic and histologic descriptions were reviewed. Rates of dysplasia detection by the different endoscopic techniques were compared using an exact Poisson test.<h4>Results</h4>76/110 (69%) had WLE (mean age 56y; median disease duration 18y) and 34/110 (31%) had CE (median age 59y; median disease duration 19y). Nonpolypoid dysplasia was detected in 0/76 (0%) patients who had WLE. Seven nonpolypoid dysplastic lesions were detected in 4/34 (11.8%) patients who had CE. Dysplasia pick up rate was significantly higher in the CE group with a risk difference of 11.8%, 95% confidence interval (0.93, 22.59), p=0.008. Dysplasia detection rate per patient was also significantly higher in the CE group with a rate difference of 20.6 lesions per 100 patients, 95% confidence interval (5.3, 35.8), p=0.0003. As expected, there was no difference between the number of polypoid dysplastic lesions found between the two groups (p=0.12).<h4>Conclusion</h4>In our cohort of IBD patients undergoing surveillance colonoscopy, CE with targeted biopsy is associated with a significantly increased nonpolypoid dysplasia detection rate when compared to WLE. These results are comparable to studies performed in the rest of the world.
dc.format.medium Electronic
dc.language eng
dc.publisher NEW ZEALAND MEDICAL ASSOC
dc.relation.ispartofseries The New Zealand medical journal
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm
dc.rights.uri https://journal.nzma.org.nz/journal/contribute
dc.subject Humans
dc.subject Colonic Neoplasms
dc.subject Inflammatory Bowel Diseases
dc.subject Colonoscopy
dc.subject Endoscopy
dc.subject Population Surveillance
dc.subject Sensitivity and Specificity
dc.subject Retrospective Studies
dc.subject Middle Aged
dc.subject Coloring Agents
dc.subject Female
dc.subject Male
dc.subject Early Detection of Cancer
dc.subject Tertiary Healthcare
dc.subject Clinical Research
dc.subject Inflammatory Bowel Disease
dc.subject Prevention
dc.subject Aging
dc.subject Autoimmune Disease
dc.subject Cancer
dc.subject Digestive Diseases
dc.subject Colo-Rectal Cancer
dc.subject 4.2 Evaluation of markers and technologies
dc.subject 4 Detection, screening and diagnosis
dc.subject Oral and gastrointestinal
dc.subject Science & Technology
dc.subject Life Sciences & Biomedicine
dc.subject Medicine, General & Internal
dc.subject General & Internal Medicine
dc.subject WHITE-LIGHT ENDOSCOPY
dc.subject ULCERATIVE-COLITIS
dc.subject COLORECTAL-CANCER
dc.subject NEOPLASIA DETECTION
dc.subject RANDOM BIOPSIES
dc.subject INDIGO CARMINE
dc.subject NEW-ZEALAND
dc.subject SURVEILLANCE
dc.subject METAANALYSIS
dc.subject GUIDELINES
dc.subject 1117 Public Health and Health Services
dc.subject Clinical
dc.subject Clinical Medicine and Science
dc.subject 11 Medical and Health Sciences
dc.title Chromoendoscopy versus standard colonoscopy for detection of nonpolypoid dysplasia in patients with inflammatory bowel disease.
dc.type Journal Article
pubs.issue 1478
pubs.begin-page 32
pubs.volume 131
dc.date.updated 2023-06-28T03:45:07Z
dc.rights.holder Copyright: The authors en
dc.identifier.pmid 30001304 (pubmed)
pubs.author-url https://journal.nzma.org.nz/journal-articles/chromoendoscopy-versus-standard-colonoscopy-for-detection-of-nonpolypoid-dysplasia-in-patients-with-inflammatory-bowel-disease
pubs.end-page 38
pubs.publication-status Published
dc.rights.accessrights http://purl.org/eprint/accessRights/OpenAccess en
pubs.subtype Comparative Study
pubs.subtype Journal Article
pubs.elements-id 776570
pubs.org-id Science
pubs.org-id Statistics
dc.identifier.eissn 1175-8716
pubs.record-created-at-source-date 2023-06-28
pubs.online-publication-date 2018-07-13


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics